nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?
|
Theocharopoulos, Charalampos |
|
|
129 |
C |
p. |
artikel |
2 |
Brachytherapy and external beam radiation in the management of primary penile cancer – Game changer for organ preservation?
|
Garaz, Radion |
|
|
129 |
C |
p. |
artikel |
3 |
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC
|
Andrini, Elisa |
|
|
129 |
C |
p. |
artikel |
4 |
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma
|
De Simoni, Edoardo |
|
|
129 |
C |
p. |
artikel |
5 |
Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer
|
Marinello, Arianna |
|
|
129 |
C |
p. |
artikel |
6 |
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumors
|
Panzuto, Francesco |
|
|
129 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
129 |
C |
p. |
artikel |
8 |
Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck
|
O’Leary, Ben |
|
|
129 |
C |
p. |
artikel |
9 |
Extracellular vesicles and the “six Rs” in radiotherapy
|
Ripoll-Viladomiu, Isabel |
|
|
129 |
C |
p. |
artikel |
10 |
HER-2 directed therapies across gastrointestinal tract cancers – A new frontier
|
Jones, Lauren |
|
|
129 |
C |
p. |
artikel |
11 |
Hormone receptor-positive early breast cancer in young women: A comprehensive review
|
Walbaum, Benjamin |
|
|
129 |
C |
p. |
artikel |
12 |
Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review
|
Brown, Janet |
|
|
129 |
C |
p. |
artikel |
13 |
Liquid biopsy: An arsenal for tumour screening and early diagnosis
|
Zhang, Qi |
|
|
129 |
C |
p. |
artikel |
14 |
Locally advanced and metastatic endometrial cancer: Current and emerging therapies
|
Salmon, Alixe |
|
|
129 |
C |
p. |
artikel |
15 |
Long road towards effective HER3 targeting in breast cancer
|
Papa, Francesca |
|
|
129 |
C |
p. |
artikel |
16 |
Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review
|
Socha, Joanna |
|
|
129 |
C |
p. |
artikel |
17 |
Overview of BH3 mimetics in ovarian cancer
|
Del Bufalo, Donatella |
|
|
129 |
C |
p. |
artikel |
18 |
Peripheral T-cell lymphoma: From biology to practice to the future
|
O'Connor, Owen A. |
|
|
129 |
C |
p. |
artikel |
19 |
Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes
|
Calabrese, A. |
|
|
129 |
C |
p. |
artikel |
20 |
Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration
|
Raoul, Jean-Luc |
|
|
129 |
C |
p. |
artikel |
21 |
Revisiting ovarian function suppression with GnRH agonists for premenopausal women with breast cancer: Who should use and the impact on survival outcomes
|
Ma, Linxiaoxi |
|
|
129 |
C |
p. |
artikel |
22 |
Targeting HIF-2α and anemia: A therapeutic breakthrough for clear-cell renal cell carcinoma
|
Rioja, Patricia |
|
|
129 |
C |
p. |
artikel |
23 |
Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies
|
Lee, Ji-Hoon |
|
|
129 |
C |
p. |
artikel |
24 |
Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act
|
Tiersma, J.F. |
|
|
129 |
C |
p. |
artikel |
25 |
The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
|
Zhang, Yaowen |
|
|
129 |
C |
p. |
artikel |
26 |
Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma
|
Loftus, Alexander W. |
|
|
129 |
C |
p. |
artikel |
27 |
The role of locoregional surgery in de novo stage IV breast cancer: A meta-analysis of randomized controlled trials
|
Zhou, Wenqi |
|
|
129 |
C |
p. |
artikel |
28 |
Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literature
|
Désage, Anne-Laure |
|
|
129 |
C |
p. |
artikel |
29 |
Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials
|
Bortolot, Martina |
|
|
129 |
C |
p. |
artikel |